Response rates according to ACR Ped 30 after 12 weeks of treatment [clinicaltrials_resource:38ca3c165ba89830e3509611859681f5]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Response rates according to ACR Ped 30 after 12 weeks of treatment [clinicaltrials_resource:38ca3c165ba89830e3509611859681f5]
Bio2RDF identifier
38ca3c165ba89830e3509611859681f5
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:38ca3c165ba89830e3509611859681f5
measure [clinicaltrials_vocabulary:measure]
Response rates according to ACR Ped 30
time frame [clinicaltrials_vocabulary:time-frame]
after 12 weeks of treatment
identifier
clinicaltrials_resource:38ca3c165ba89830e3509611859681f5
title
Response rates according to ACR Ped 30 after 12 weeks of treatment
@en
type
label
Response rates according to AC ...... a3c165ba89830e3509611859681f5]
@en